Global Transdermal Patches Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application
This report aims to provide a comprehensive presentation of the global market for Transdermal Patches, with and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal Patches.
The Transdermal Patches market size considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Transdermal Patches market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transdermal Patches manufacturers, new entrants, and industry chain related companies in this market with information for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
The global Transdermal Patches market size in 2022 is 7130.0 million US dollars, and it is expected to be XX million US dollars by 2029, with a compound annual growth rate of 4.90% expected in 2023-2029.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Transdermal Patches market include AdhexPharma (France), ProSolus, Inc (U.S.), Tapemark (U.S.), tesa Tapes (India) Pvt. Ltd. (Germany), and Nitto Denko Corporation. (Japan). The share of the top 3 players in the Transdermal Patches market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Transdermal Patches market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Single-Layer Drug-In-Adhesive accounted for XX% of Transdermal Patches market in 2022. Multi-Layer Drug-In-Adhesive share of XX%.
Cardiovascular Disorder accounted for XX% of the Transdermal Patches market in 2022. Central Nervous System Disorders (CNS) accounts for XX%.
Recent developments in the materials and chemicals industry have been influenced by various factors, including sustainability concerns, technological advancements, and changing consumer demands.
Sustainable Materials: There is a growing emphasis on sustainable materials and processes in the industry. Companies are focusing on developing bio-based and recycled materials to reduce dependence on fossil fuels and minimize environmental impact. This includes the use of bioplastics, bio-based polymers, and renewable feedstocks in various applications.
Circular Economy: The concept of a circular economy, which aims to minimize waste and maximize resource efficiency, has gained significant attention. Companies are exploring innovative solutions for recycling, upcycling, and reusing materials to create closed-loop systems. This involves developing new recycling technologies, implementing take-back programs, and designing products with end-of-life considerations in mind.
Digitalization and Industry 4.0: The integration of digital technologies, automation, and data analytics is transforming the materials and chemicals industry. Smart manufacturing, Internet of Things (IoT) sensors, and artificial intelligence (AI) are being employed to optimize production processes, improve quality control, and enhance supply chain efficiency. This digital transformation is enhancing productivity, reducing costs, and enabling predictive maintenance.
Regions Covered in This Report Are
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
South America
Brazil
Argentina
Colombia
MEA
Saudi Arabia
Egypt
Nigeria
Some of the Top Key Players:
AdhexPharma (France)
ProSolus, Inc (U.S.)
Tapemark (U.S.)
tesa Tapes (India) Pvt. Ltd. (Germany)
Nitto Denko Corporation. (Japan)
Noven Pharmaceuticals, Inc (U.S.)
LTS Lohmann Therapie-Systeme AG (Germany)
Medherant Limited (U.K.)
Corium, Inc. (U.S.)
Bayer AG (Germany)
Novartis AG (Switzerland)
Antares Pharma (U.S.)
Abbott. (U.S.)
Medipatch, Inc. (U.S.)
Mylan N.V. (U.S.)
Acrux Limited (Australia)
Sparsha Pharma International Pvt Ltd (India)
Bliss GVS Pharma. (India)
Johnson & Johnson (U.S.)
Informa PLC (U.K.)
Product Types Outlook
Single-Layer Drug-In-Adhesive
Multi-Layer Drug-In-Adhesive
Matrix
Reservoir
Vapor
Others
Application Outlook
Cardiovascular Disorder
Central Nervous System Disorders (CNS)
Pain Management/ Relief
Smoking Reduction and Cessation Aid
Overactive Bladder
Nicotine Cessation
Hormonal Therapy/ Disorders
Dermatology
Others
Table of Content
1 Transdermal Patches Market Overview
1.1 Transdermal Patches Product Description
1.2 Transdermal Patches Market Segment by Type
1.3 Global Transdermal Patches Market Size by Type
1.3.1 Global Transdermal Patches Market Size Overview by Type
1.3.2 Global Transdermal Patches Historic Market Size Review by Type
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Transdermal Patches Sales Breakdown by Type
1.4.2 Europe Transdermal Patches Sales Breakdown by Type
1.4.3 Asia-Pacific Transdermal Patches Sales Breakdown by Type
1.4.4 Latin America Transdermal Patches Sales Breakdown by Type
1.4.5 Middle East and Africa Transdermal Patches Sales Breakdown by Type
2 Global Transdermal Patches by Application
2.1 Transdermal Patches Market Segment by Application
2.2 Global Transdermal Patches Market Size by Application
2.2.1 Global Transdermal Patches Market Size Overview by Application
2.2.2 Global Transdermal Patches Historic Market Size Review by Application
2.3 Key Regions Market Size Segment by Application
2.3.1 North America Transdermal Patches Sales Breakdown by Application
2.3.2 Europe Transdermal Patches Sales Breakdown by Application
2.3.3 Asia-Pacific Transdermal Patches Sales Breakdown by Application
2.3.4 Latin America Transdermal Patches Sales Breakdown by Application
2.3.5 Middle East and Africa Transdermal Patches Sales Breakdown by Application
3 Transdermal Patches Status and Outlook by Region
3.1 Global Transdermal Patches Market Size and CAGR by Region: 2018 VS 2023 VS 2029
3.2 Global Transdermal Patches Historic Market Size by Region
3.2.1 Global Transdermal Patches Sales in Volume by Region
3.2.2 Global Transdermal Patches Sales in Value by Region
3.2.3 Global Transdermal Patches Sales Price and Gross Margin
3.3 Global Transdermal Patches Forecasted Market Size by Region
3.3.1 Global Transdermal Patches Sales in Volume by Region
3.3.2 Global Transdermal Patches Sales in Value by Region
3.3.3 Global Transdermal Patches Sales Price and Gross Margin
4 Global Transdermal Patches Market Competition by Company
4.1 Global Top Players by Transdermal Patches Sales
4.2 Global Top Players by Transdermal Patches Revenue
4.3 Global Top Players Transdermal Patches Price
4.4 Global Top Manufacturers Transdermal Patches Manufacturing Base Distribution, Sales Area, Product Type
4.5 Transdermal Patches Market Competitive Situation and Trends
4.5.1 Transdermal Patches Market Concentration Rate
4.5.2 Global 3 and 6 Largest Manufacturers by Transdermal Patches Sales and Revenue in 2022
4.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Transdermal Patches as of 2022)
4.7 Date of Key Manufacturers Enter into Transdermal Patches Market
4.8 Key Manufacturers Transdermal Patches Product Offered
4.9 Mergers & Acquisitions, Expansion
5 North America Transdermal Patches by Country
5.1 North America Transdermal Patches Historic Market Size by Country
5.1.1 North America Transdermal Patches Sales in Volume by Country
5.1.2 North America Transdermal Patches Sales in Value by Country
5.2 North America Transdermal Patches Forecasted Market Size by Country
5.2.1 North America Transdermal Patches Sales in Volume by Country
5.2.2 North America Transdermal Patches Sales in Value by Country
6 Europe Transdermal Patches by Country
6.1 Europe Transdermal Patches Historic Market Size by Country
6.1.1 Europe Transdermal Patches Sales in Volume by Country
6.1.2 Europe Transdermal Patches Sales in Value by Country
6.2 Europe Transdermal Patches Forecasted Market Size by Country
6.2.1 Europe Transdermal Patches Sales in Volume by Country
6.2.2 Europe Transdermal Patches Sales in Value by Country
7 Asia-Pacific Transdermal Patches by Country
7.1 Asia-Pacific Transdermal Patches Historic Market Size by Country
7.1.1 Asia-Pacific Transdermal Patches Sales in Volume by Country
7.1.2 Asia-Pacific Transdermal Patches Sales in Value by Country
7.2 Asia-Pacific Transdermal Patches Forecasted Market Size by Country
7.2.1 Asia-Pacific Transdermal Patches Sales in Volume by Country
7.2.2 Asia-Pacific Transdermal Patches Sales in Value by Country
8 Latin America Transdermal Patches by Country
8.1 Latin America Transdermal Patches Historic Market Size by Country
8.1.1 Latin America Transdermal Patches Sales in Volume by Country
8.1.2 Latin America Transdermal Patches Sales in Value by Country
8.2 Latin America Transdermal Patches Forecasted Market Size by Country
8.2.1 8.2.1 Latin America Transdermal Patches Sales in Volume by Country
8.2.2 8.2.2 Latin America Transdermal Patches Sales in Value by Country
9 Middle East and Africa Transdermal Patches by Country
9.1 Middle East and Africa Transdermal Patches Historic Market Size by Country
9.1.1 Middle East and Africa Transdermal Patches Sales in Volume by Country
9.1.2 Middle East and Africa Transdermal Patches Sales in Value by Country
9.2 Middle East and Africa Transdermal Patches Forecasted Market Size by Country
9.2.1 Middle East and Africa Transdermal Patches Sales in Volume by Country
9.2.2 Middle East and Africa Transdermal Patches Sales in Value by Country
10 Manufacturers Profiles
10.1 AdhexPharma (France)
10.1.1 AdhexPharma (France) Information
10.1.2 Business Overview
10.1.3 AdhexPharma (France) Transdermal Patches Sales, Price, Revenue, Gross Margin
10.1.4 Transdermal Patches Products Offered
10.1.5 AdhexPharma (France) Recent Development
10.2 ProSolus, Inc (U.S.)
10.2.1 ProSolus, Inc (U.S.) Information
10.2.2 Business Overview
10.2.3 ProSolus, Inc (U.S.) Transdermal Patches Sales, Price, Revenue, Gross Margin
10.2.4 Transdermal Patches Products Offered
10.2.5 ProSolus, Inc (U.S.) Recent Development
10.3 Tapemark (U.S.)
10.3.1 Tapemark (U.S.) Information
10.3.2 Business Overview
10.3.3 Tapemark (U.S.) Transdermal Patches Sales, Price, Revenue, Gross Margin
10.3.4 Transdermal Patches Products Offered
10.3.5 Tapemark (U.S.) Recent Development
10.4 tesa Tapes (India) Pvt. Ltd. (Germany)
10.4.1 tesa Tapes (India) Pvt. Ltd. (Germany) Information
10.4.2 Business Overview
10.4.3 tesa Tapes (India) Pvt. Ltd. (Germany) Transdermal Patches Sales, Price, Revenue, Gross Margin
10.4.4 Transdermal Patches Products Offered
10.4.5 tesa Tapes (India) Pvt. Ltd. (Germany) Recent Development
10.5 Nitto Denko Corporation. (Japan)
10.5.1 Nitto Denko Corporation. (Japan) Information
10.5.2 Business Overview
10.5.3 Nitto Denko Corporation. (Japan) Transdermal Patches Sales, Price, Revenue, Gross Margin
10.5.4 Transdermal Patches Products Offered
10.5.5 Nitto Denko Corporation. (Japan) Recent Development
10.6 Noven Pharmaceuticals, Inc (U.S.)
10.6.1 Noven Pharmaceuticals, Inc (U.S.) Information
10.6.2 Business Overview
10.6.3 Noven Pharmaceuticals, Inc (U.S.) Transdermal Patches Sales, Price, Revenue, Gross Margin
10.6.4 Transdermal Patches Products Offered
10.6.5 Noven Pharmaceuticals, Inc (U.S.) Recent Development
10.7 LTS Lohmann Therapie-Systeme AG (Germany)
10.7.1 LTS Lohmann Therapie-Systeme AG (Germany) Information
10.7.2 Business Overview
10.7.3 LTS Lohmann Therapie-Systeme AG (Germany) Transdermal Patches Sales, Price, Revenue, Gross Margin
10.7.4 Transdermal Patches Products Offered
10.7.5 LTS Lohmann Therapie-Systeme AG (Germany) Recent Development
10.8 Medherant Limited (U.K.)
10.8.1 Medherant Limited (U.K.) Information
10.8.2 Business Overview
10.8.3 Medherant Limited (U.K.) Transdermal Patches Sales, Price, Revenue, Gross Margin
10.8.4 Transdermal Patches Products Offered
10.8.5 Medherant Limited (U.K.) Recent Development
10.9 Corium, Inc. (U.S.)
10.9.1 Corium, Inc. (U.S.) Information
10.9.2 Business Overview
10.9.3 Corium, Inc. (U.S.) Transdermal Patches Sales, Price, Revenue, Gross Margin
10.9.4 Transdermal Patches Products Offered
10.9.5 Corium, Inc. (U.S.) Recent Development
10.10 Bayer AG (Germany)
10.10.1 Bayer AG (Germany) Information
10.10.2 Business Overview
10.10.3 Bayer AG (Germany) Transdermal Patches Sales, Price, Revenue, Gross Margin
10.10.4 Transdermal Patches Products Offered
10.10.5 Bayer AG (Germany) Recent Development
10.11 Novartis AG (Switzerland)
10.11.1 Novartis AG (Switzerland) Information
10.11.2 Business Overview
10.11.3 Novartis AG (Switzerland) Transdermal Patches Sales, Price, Revenue, Gross Margin
10.11.4 Transdermal Patches Products Offered
10.11.5 Novartis AG (Switzerland) Recent Development
10.12 Antares Pharma (U.S.)
10.12.1 Antares Pharma (U.S.) Information
10.12.2 Business Overview
10.12.3 Antares Pharma (U.S.) Transdermal Patches Sales, Price, Revenue, Gross Margin
10.12.4 Transdermal Patches Products Offered
10.12.5 Antares Pharma (U.S.) Recent Development
10.13 Abbott. (U.S.)
10.13.1 Abbott. (U.S.) Information
10.13.2 Business Overview
10.13.3 Abbott. (U.S.) Transdermal Patches Sales, Price, Revenue, Gross Margin
10.13.4 Transdermal Patches Products Offered
10.13.5 Abbott. (U.S.) Recent Development
10.14 Medipatch, Inc. (U.S.)
10.14.1 Medipatch, Inc. (U.S.) Information
10.14.2 Business Overview
10.14.3 Medipatch, Inc. (U.S.) Transdermal Patches Sales, Price, Revenue, Gross Margin
10.14.4 Transdermal Patches Products Offered
10.14.5 Medipatch, Inc. (U.S.) Recent Development
10.15 Mylan N.V. (U.S.)
10.15.1 Mylan N.V. (U.S.) Information
10.15.2 Business Overview
10.15.3 Mylan N.V. (U.S.) Transdermal Patches Sales, Price, Revenue, Gross Margin
10.15.4 Transdermal Patches Products Offered
10.15.5 Mylan N.V. (U.S.) Recent Development
10.16 Acrux Limited (Australia)
10.16.1 Acrux Limited (Australia) Information
10.16.2 Business Overview
10.16.3 Acrux Limited (Australia) Transdermal Patches Sales, Price, Revenue, Gross Margin
10.16.4 Transdermal Patches Products Offered
10.16.5 Acrux Limited (Australia) Recent Development
10.17 Sparsha Pharma International Pvt Ltd (India)
10.17.1 Sparsha Pharma International Pvt Ltd (India) Information
10.17.2 Business Overview
10.17.3 Sparsha Pharma International Pvt Ltd (India) Transdermal Patches Sales, Price, Revenue, Gross Margin
10.17.4 Transdermal Patches Products Offered
10.17.5 Sparsha Pharma International Pvt Ltd (India) Recent Development
10.18 Bliss GVS Pharma. (India)
10.18.1 Bliss GVS Pharma. (India) Information
10.18.2 Business Overview
10.18.3 Bliss GVS Pharma. (India) Transdermal Patches Sales, Price, Revenue, Gross Margin
10.18.4 Transdermal Patches Products Offered
10.18.5 Bliss GVS Pharma. (India) Recent Development
10.19 Johnson & Johnson (U.S.)
10.19.1 Johnson & Johnson (U.S.) Information
10.19.2 Business Overview
10.19.3 Johnson & Johnson (U.S.) Transdermal Patches Sales, Price, Revenue, Gross Margin
10.19.4 Transdermal Patches Products Offered
10.19.5 Johnson & Johnson (U.S.) Recent Development
10.20 Informa PLC (U.K.)
10.20.1 Informa PLC (U.K.) Information
10.20.2 Business Overview
10.20.3 Informa PLC (U.K.) Transdermal Patches Sales, Price, Revenue, Gross Margin
10.20.4 Transdermal Patches Products Offered
10.20.5 Informa PLC (U.K.) Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Transdermal Patches Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Transdermal Patches Industrial Chain Analysis
11.4 Transdermal Patches Market Dynamics
11.4.1 Transdermal Patches Industry Trends
11.4.2 Transdermal Patches Growth Drivers
11.4.3 Transdermal Patches Market Challenges
11.4.4 Transdermal Patches Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Transdermal Patches Distributors
12.3 Transdermal Patches Downstream Customers
13 Research Findings and Conclusion
14 Methodology and Data Source
14.1 A Methodology
14.1.1 Research Process
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 B Data Source
14.2.1 Legal Disclaimer
List of Tables and Figures
Figure Global Transdermal Patches Market Size Overview by Type
Table Global Transdermal Patches Sales Breakdown in Volume, by Type
Table Global Transdermal Patches Sales Breakdown in Value, by Type
Table Global Transdermal Patches Average Selling Price (ASP) by Type
Table Global Transdermal Patches Sales Breakdown in Volume, by Type (2023-2029)
Table Global Transdermal Patches Sales Breakdown in Value, by Type (2023-2029)
Table Global Transdermal Patches Average Selling Price (ASP) by Type (2023-2029)
Table North America Transdermal Patches Sales Breakdown in Volume, by Type
Table Europe Transdermal Patches Sales Breakdown in Volume, by Type
Table Asia-Pacific Transdermal Patches Sales Breakdown in Volume, by Type
Table Latin America Transdermal Patches Sales Breakdown in Volume, by Type
Table Middle East and Africa Transdermal Patches Sales Breakdown in Volume, by Type
Figure Global Transdermal Patches Market Size Overview by Application
Table Global Transdermal Patches Sales Breakdown in Volume, by Application
Table Global Transdermal Patches Sales Breakdown in Value, by Application
Table Global Transdermal Patches Average Selling Price (ASP) by Application
Table Global Transdermal Patches Sales Breakdown in Volume, by Application (2023-2029)
Table Global Transdermal Patches Sales Breakdown in Value, by Application (2023-2029)
Table Global Transdermal Patches Average Selling Price (ASP) by Application (2023-2029)
Table North America Transdermal Patches Sales Breakdown in Volume, by Application
Table Europe Transdermal Patches Sales Breakdown in Volume, by Application
Table Asia-Pacific Transdermal Patches Sales Breakdown in Volume, by Application
Table Latin America Transdermal Patches Sales Breakdown in Volume, by Application
Table Middle East and Africa Transdermal Patches Sales Breakdown in Volume, by Application
Table Global Transdermal Patches Market Size and CAGR by Region: 2018 VS 2023 VS 2029
Table Global Transdermal Patches Sales in Volume by Region
Table Global Transdermal Patches Sales in Value by Region
Table Global Transdermal Patches Sales Price and Gross Margin
Table Global Transdermal Patches Sales in Volume by Region
Table Global Transdermal Patches Sales in Value by Region
Table Global Transdermal Patches Sales Price and Gross Margin
Table Global Top Players by Transdermal Patches Sales
Table Global Top Players by Transdermal Patches Revenue
Table Global Top Players by Transdermal Patches Price
Table Global Top Manufacturers Transdermal Patches Manufacturing Base Distribution, Sales Area, Product Type
Table Transdermal Patches Market Concentration Rate
Figure Global 5 and 10 Largest Manufacturers by Transdermal Patches Sales and Revenue in 2022
Table Date of Key Manufacturers Enter into Transdermal Patches Market
Table Key Manufacturers Transdermal Patches Product Offered
Table Mergers & Acquisitions, Expansion Plans
Table North America Transdermal Patches Sales in Volume by Country
Table North America Transdermal Patches Sales in Value by Country
Table North America Transdermal Patches Sales in Volume by Country
Table North America Transdermal Patches Sales in Value by Country
Table Europe Transdermal Patches Sales in Volume by Country
Table Europe Transdermal Patches Sales in Value by Country
Table Europe Transdermal Patches Sales in Volume by Country
Table Europe Transdermal Patches Sales in Value by Country
Table Asia-Pacific Transdermal Patches Sales in Volume by Country
Table Asia-Pacific Transdermal Patches Sales in Value by Country
Table Asia-Pacific Transdermal Patches Sales in Volume by Country
Table Asia-Pacific Transdermal Patches Sales in Value by Country
Table Latin America Transdermal Patches Sales in Volume by Country
Table Latin America Transdermal Patches Sales in Value by Country
Table Latin America Transdermal Patches Sales in Volume by Country
Table Latin America Transdermal Patches Sales in Value by Country
Table Middle East and Africa Transdermal Patches Sales in Volume by Country
Table Middle East and Africa Transdermal Patches Sales in Value by Country
Table Middle East and Africa Transdermal Patches Sales in Volume by Country
Table Middle East and Africa Transdermal Patches Sales in Value by Country
Table AdhexPharma (France) Basic Information, Manufacturing Base
Table AdhexPharma (France) Transdermal Patches Sales, Price, Revenue, Gross Margin (2018-2023)
Figure AdhexPharma (France) Sales and Growth Rate
Figure AdhexPharma (France) Revenue Market Share 2018-2023
Table Transdermal Patches Products Offered
Table AdhexPharma (France) Recent Development
Table ProSolus, Inc (U.S.) Basic Information, Manufacturing Base
Table ProSolus, Inc (U.S.) Transdermal Patches Sales, Price, Revenue, Gross Margin (2018-2023)
Figure ProSolus, Inc (U.S.) Sales and Growth Rate
Figure ProSolus, Inc (U.S.) Revenue Market Share 2018-2023
Table Transdermal Patches Products Offered
Table ProSolus, Inc (U.S.) Recent Development
Table Tapemark (U.S.) Basic Information, Manufacturing Base
Table Tapemark (U.S.) Transdermal Patches Sales, Price, Revenue, Gross Margin (2018-2023)
Figure Tapemark (U.S.) Sales and Growth Rate
Figure Tapemark (U.S.) Revenue Market Share 2018-2023
Table Transdermal Patches Products Offered
Table Tapemark (U.S.) Recent Development
Table tesa Tapes (India) Pvt. Ltd. (Germany) Basic Information, Manufacturing Base
Table tesa Tapes (India) Pvt. Ltd. (Germany) Transdermal Patches Sales, Price, Revenue, Gross Margin (2018-2023)
Figure tesa Tapes (India) Pvt. Ltd. (Germany) Sales and Growth Rate
Figure tesa Tapes (India) Pvt. Ltd. (Germany) Revenue Market Share 2018-2023
Table Transdermal Patches Products Offered
Table tesa Tapes (India) Pvt. Ltd. (Germany) Recent Development
Table Nitto Denko Corporation. (Japan) Basic Information, Manufacturing Base
Table Nitto Denko Corporation. (Japan) Transdermal Patches Sales, Price, Revenue, Gross Margin (2018-2023)
Figure Nitto Denko Corporation. (Japan) Sales and Growth Rate
Figure Nitto Denko Corporation. (Japan) Revenue Market Share 2018-2023
Table Transdermal Patches Products Offered
Table Nitto Denko Corporation. (Japan) Recent Development
Table Noven Pharmaceuticals, Inc (U.S.) Basic Information, Manufacturing Base
Table Noven Pharmaceuticals, Inc (U.S.) Transdermal Patches Sales, Price, Revenue, Gross Margin (2018-2023)
Figure Noven Pharmaceuticals, Inc (U.S.) Sales and Growth Rate
Figure Noven Pharmaceuticals, Inc (U.S.) Revenue Market Share 2018-2023
Table Transdermal Patches Products Offered
Table Noven Pharmaceuticals, Inc (U.S.) Recent Development
Table LTS Lohmann Therapie-Systeme AG (Germany) Basic Information, Manufacturing Base
Table LTS Lohmann Therapie-Systeme AG (Germany) Transdermal Patches Sales, Price, Revenue, Gross Margin (2018-2023)
Figure LTS Lohmann Therapie-Systeme AG (Germany) Sales and Growth Rate
Figure LTS Lohmann Therapie-Systeme AG (Germany) Revenue Market Share 2018-2023
Table Transdermal Patches Products Offered
Table LTS Lohmann Therapie-Systeme AG (Germany) Recent Development
Table Medherant Limited (U.K.) Basic Information, Manufacturing Base
Table Medherant Limited (U.K.) Transdermal Patches Sales, Price, Revenue, Gross Margin (2018-2023)
Figure Medherant Limited (U.K.) Sales and Growth Rate
Figure Medherant Limited (U.K.) Revenue Market Share 2018-2023
Table Transdermal Patches Products Offered
Table Medherant Limited (U.K.) Recent Development
Table Corium, Inc. (U.S.) Basic Information, Manufacturing Base
Table Corium, Inc. (U.S.) Transdermal Patches Sales, Price, Revenue, Gross Margin (2018-2023)
Figure Corium, Inc. (U.S.) Sales and Growth Rate
Figure Corium, Inc. (U.S.) Revenue Market Share 2018-2023
Table Transdermal Patches Products Offered
Table Corium, Inc. (U.S.) Recent Development
Table Bayer AG (Germany) Basic Information, Manufacturing Base
Table Bayer AG (Germany) Transdermal Patches Sales, Price, Revenue, Gross Margin (2018-2023)
Figure Bayer AG (Germany) Sales and Growth Rate
Figure Bayer AG (Germany) Revenue Market Share 2018-2023
Table Transdermal Patches Products Offered
Table Bayer AG (Germany) Recent Development
Table Novartis AG (Switzerland) Basic Information, Manufacturing Base
Table Novartis AG (Switzerland) Transdermal Patches Sales, Price, Revenue, Gross Margin (2018-2023)
Figure Novartis AG (Switzerland) Sales and Growth Rate
Figure Novartis AG (Switzerland) Revenue Market Share 2018-2023
Table Transdermal Patches Products Offered
Table Novartis AG (Switzerland) Recent Development
Table Antares Pharma (U.S.) Basic Information, Manufacturing Base
Table Antares Pharma (U.S.) Transdermal Patches Sales, Price, Revenue, Gross Margin (2018-2023)
Figure Antares Pharma (U.S.) Sales and Growth Rate
Figure Antares Pharma (U.S.) Revenue Market Share 2018-2023
Table Transdermal Patches Products Offered
Table Antares Pharma (U.S.) Recent Development
Table Abbott. (U.S.) Basic Information, Manufacturing Base
Table Abbott. (U.S.) Transdermal Patches Sales, Price, Revenue, Gross Margin (2018-2023)
Figure Abbott. (U.S.) Sales and Growth Rate
Figure Abbott. (U.S.) Revenue Market Share 2018-2023
Table Transdermal Patches Products Offered
Table Abbott. (U.S.) Recent Development
Table Medipatch, Inc. (U.S.) Basic Information, Manufacturing Base
Table Medipatch, Inc. (U.S.) Transdermal Patches Sales, Price, Revenue, Gross Margin (2018-2023)
Figure Medipatch, Inc. (U.S.) Sales and Growth Rate
Figure Medipatch, Inc. (U.S.) Revenue Market Share 2018-2023
Table Transdermal Patches Products Offered
Table Medipatch, Inc. (U.S.) Recent Development
Table Mylan N.V. (U.S.) Basic Information, Manufacturing Base
Table Mylan N.V. (U.S.) Transdermal Patches Sales, Price, Revenue, Gross Margin (2018-2023)
Figure Mylan N.V. (U.S.) Sales and Growth Rate
Figure Mylan N.V. (U.S.) Revenue Market Share 2018-2023
Table Transdermal Patches Products Offered
Table Mylan N.V. (U.S.) Recent Development
Table Acrux Limited (Australia) Basic Information, Manufacturing Base
Table Acrux Limited (Australia) Transdermal Patches Sales, Price, Revenue, Gross Margin (2018-2023)
Figure Acrux Limited (Australia) Sales and Growth Rate
Figure Acrux Limited (Australia) Revenue Market Share 2018-2023
Table Transdermal Patches Products Offered
Table Acrux Limited (Australia) Recent Development
Table Sparsha Pharma International Pvt Ltd (India) Basic Information, Manufacturing Base
Table Sparsha Pharma International Pvt Ltd (India) Transdermal Patches Sales, Price, Revenue, Gross Margin (2018-2023)
Figure Sparsha Pharma International Pvt Ltd (India) Sales and Growth Rate
Figure Sparsha Pharma International Pvt Ltd (India) Revenue Market Share 2018-2023
Table Transdermal Patches Products Offered
Table Sparsha Pharma International Pvt Ltd (India) Recent Development
Table Bliss GVS Pharma. (India) Basic Information, Manufacturing Base
Table Bliss GVS Pharma. (India) Transdermal Patches Sales, Price, Revenue, Gross Margin (2018-2023)
Figure Bliss GVS Pharma. (India) Sales and Growth Rate
Figure Bliss GVS Pharma. (India) Revenue Market Share 2018-2023
Table Transdermal Patches Products Offered
Table Bliss GVS Pharma. (India) Recent Development
Table Johnson & Johnson (U.S.) Basic Information, Manufacturing Base
Table Johnson & Johnson (U.S.) Transdermal Patches Sales, Price, Revenue, Gross Margin (2018-2023)
Figure Johnson & Johnson (U.S.) Sales and Growth Rate
Figure Johnson & Johnson (U.S.) Revenue Market Share 2018-2023
Table Transdermal Patches Products Offered
Table Johnson & Johnson (U.S.) Recent Development
Table Informa PLC (U.K.) Basic Information, Manufacturing Base
Table Informa PLC (U.K.) Transdermal Patches Sales, Price, Revenue, Gross Margin (2018-2023)
Figure Informa PLC (U.K.) Sales and Growth Rate
Figure Informa PLC (U.K.) Revenue Market Share 2018-2023
Table Transdermal Patches Products Offered
Table Informa PLC (U.K.) Recent Development
Table Key Raw Materials Price
Table Key Suppliers of Raw Materials
Figure Proportion of Manufacturing Cost Structure
Table Transdermal Patches Chain Analysis
Figure Marketing Channel
Table Major Distributors of Transdermal Patches with Contact Information
Table Major Customers of Transdermal Patches with Contact Information
Table Research Process
Figure Bottom-up and Top-down Approaches for This Report
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|